60
Participants
Start Date
May 1, 2014
Primary Completion Date
October 1, 2014
Study Completion Date
January 1, 2016
aspirin 100 mg bis in die
Patient will be randomized and after 10 days and 30 days we will measure platelets aggregation.
aspririn 200 mg once daily
Patient will be randomized and after 10 days and 30 days we will measure platelets aggregation.
aspirin 100 mg once daily
Patient will be randomized and after 10 days and 30 days we will measure platelets aggregation.
Azienda Ospedaliera Universitaria Federico II, Naples
Federico II University
OTHER